title: Type I Interferon Regulates the Expression of Long Non-Coding RNAs.
abstract: Interferons (IFNs) are key players in the antiviral response. IFN sensing by the cell activates transcription of IFN-stimulated genes (ISGs) able to induce an antiviral state by affecting viral replication and release. IFN also induces the expression of ISGs that function as negative regulators to limit the strength and duration of IFN response. The ISGs identified so far belong to coding genes. However, only a small proportion of the transcriptome corresponds to coding transcripts and it has been estimated that there could be as many coding as long non-coding RNAs (lncRNAs). To address whether IFN can also regulate the expression of lncRNAs, we analyzed the transcriptome of HuH7 cells treated or not with IFNα2 by expression arrays. Analysis of the arrays showed increased levels of several well-characterized coding genes that respond to IFN both at early or late times. Furthermore, we identified several IFN-stimulated or -downregulated lncRNAs (ISRs and IDRs). Further validation showed that ISR2, 8, and 12 expression mimics that of their neighboring genes GBP1, IRF1, and IL6, respectively, all related to the IFN response. These genes are induced in response to different doses of IFNα2 in different cell lines at early (ISR2 or 8) or later (ISR12) time points. IFNβ also induced the expression of these lncRNAs. ISR2 and 8 were also induced by an influenza virus unable to block the IFN response but not by other wild-type lytic viruses tested. Surprisingly, both ISR2 and 8 were significantly upregulated in cultured cells and livers from patients infected with HCV. Increased levels of ISR2 were also detected in patients chronically infected with HIV. This is relevant as genome-wide guilt-by-association studies predict that ISR2, 8, and 12 may function in viral processes, in the IFN pathway and the antiviral response. Therefore, we propose that these lncRNAs could be induced by IFN to function as positive or negative regulators of the antiviral response.
authors.affiliation: Department of Gene therapy and Hepatology, Center for Applied Medical Research (CIMA), University of Navarra , Pamplona , Spain.
authors.forename: Elena
authors.initials: E
authors.lastname: Carnero
authors.affiliation: Department of Gene therapy and Hepatology, Center for Applied Medical Research (CIMA), University of Navarra , Pamplona , Spain.
authors.forename: Marina
authors.initials: M
authors.lastname: Barriocanal
authors.affiliation: Bioinformatics Unit, Center for Applied Medical Research (CIMA), University of Navarra , Pamplona , Spain.
authors.forename: Victor
authors.initials: V
authors.lastname: Segura
authors.affiliation: Bioinformatics Unit, Center for Applied Medical Research (CIMA), University of Navarra , Pamplona , Spain.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Guruceaga
authors.affiliation: Department of Gene therapy and Hepatology, Center for Applied Medical Research (CIMA), University of Navarra , Pamplona , Spain.
authors.forename: Celia
authors.initials: C
authors.lastname: Prior
authors.affiliation: Centre for Infectious Diseases/Virology, Heidelberg University Hospital, Cluster of Excellence CellNetworks , Heidelberg , Germany ; German Center for Infection Research (DZIF) , Heidelberg , Germany.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Börner
authors.affiliation: Centre for Infectious Diseases/Virology, Heidelberg University Hospital, Cluster of Excellence CellNetworks , Heidelberg , Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Grimm
authors.affiliation: Department of Gene therapy and Hepatology, Center for Applied Medical Research (CIMA), University of Navarra , Pamplona , Spain.
authors.forename: Puri
authors.initials: P
authors.lastname: Fortes
keywords: GBP1; HCV; HIV; IFN; IRF1; lncRNAs; viral infection